Gene: EMB
Official Full Name: embiginprovided by HGNC
Gene Summary: This gene encodes a transmembrane glycoprotein that is a member of the immunoglobulin superfamily. The encoded protein may be involved in cell growth and development by mediating interactions between the cell and extracellular matrix. A pseudogene of this gene is found on chromosome 1. [provided by RefSeq, Jan 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26489 | EMB Knockout cell line (HeLa) | Human | EMB | 1:3~1:6 | Negative | Online Inquiry |
KO26490 | EMB Knockout cell line (HCT 116) | Human | EMB | 1:2~1:4 | Negative | Online Inquiry |
KO26491 | EMB Knockout cell line (HEK293) | Human | EMB | 1:3~1:6 | Negative | Online Inquiry |
KO26492 | EMB Knockout cell line (A549) | Human | EMB | 1:3~1:4 | Negative | Online Inquiry |
EMB Gene Knockout Cell Lines are precisely engineered cellular models that facilitate the functional analysis of specific genes by creating targeted deletions in the genome. These cell lines serve as powerful tools in genetic research, providing insights into gene function, regulatory processes, and the mechanisms of various diseases. By utilizing advanced CRISPR-Cas9 technology, EMB Gene Knockout Cell Lines can effectively silence gene expression, allowing researchers to study the phenotypic consequences of gene loss and understand essential pathways within cellular contexts.
The key mechanisms underlying the functionality of these cell lines involve the introduction of targeted double-strand breaks in specific genes, followed by the cell’s natural repair processes that result in indel mutations, effectively knocking out the desired gene. This method not only ensures high efficiency but also specificity, minimizing off-target effects that can confound experimental outcomes. Researchers can use these knockout models for a variety of applications, ranging from drug discovery and toxicology assessments to elucidating genetic contributions to complex diseases.
What sets EMB Gene Knockout Cell Lines apart from other gene editing solutions is their rigorous validation, which includes comprehensive genotyping and functional assays to confirm successful gene disruption. This level of quality assurance ensures that users can confidently rely on these models for reproducible results. Additionally, the availability of a diverse array of cell lines targeting various genes expedites the research process, allowing for tailoring experiments to specific hypotheses without the extensive time investment of generating new knockout models.
Target users, including researchers and clinicians, will find these cell lines valuable for their ability to elucidate gene functions and contribute to the advancement of personalized medicine approaches. By understanding the implications of genetic modifications in disease contexts, EMB Gene Knockout Cell Lines pave the way for potential therapeutic interventions and innovative research developments.
With a commitment to scientific excellence and innovation, our company draws upon years of expertise in cellular technology and genetics, ensuring that EMB Gene Knockout Cell Lines meet the highest standards for research applications. We are dedicated to empowering researchers by providing tools that enhance the exploration of genetic functions, ultimately leading to breakthroughs in health and disease understanding.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.